European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Medical microbots to support new assisted reproduction techniques

Description du projet

Utiliser des microbots pour faciliter la fécondation

Le projet MicroRepro repose sur une technologie de pointe utilisant des microbots médicaux pour faire propulser le sperme en vue de la fécondation d’un ovocyte. Avec près de 50 millions de couples infertiles dans le monde, il est urgent de trouver des alternatives avancées pour l’insémination artificielle, dont le taux de réussite est inférieur à 30 %, et pour la fécondation in vitro, certes plus efficace mais aussi plus invasive. Le projet MicroRepro propose une méthode plus proche d’un processus naturel, en utilisant et en améliorant certaines avancées en nanotechnologie et en microrobotique. Son équipe comprend un chercheur principal (PI) qui a inventé un dispositif qui y contribue (Spermbot). Ses perspectives prometteuses devraient contribuer à résoudre un problème médical critique tout en stimulant la recherche en bioimagerie, en nanosciences et en biologie.

Objectif

Infertility is a health issue with sociological and psychological implications that affects approximately 50 million couples worldwide and therefore receives global attention. Among fertility issues, male infertility is diagnosed in about 40% of all cases and the major causes are poor motility of spermatozoa (asthenospermia), low sperm count (oligospermia), abnormal sperm morphology (teratospermia) and/or combinations of these, leading to their inability to fertilize an oocyte. Such problems have been mainly addressed by artificial insemination (AI) and in vitro fertilization (IVF). AI involves introducing sperms into a woman’s uterus with a medical instrument, but its applicability is limited and its success rate is below 30%. In contrast, IVF and intracytoplasmic sperm injection can be more effective but implicate more invasive procedures such as removing oocytes from a woman’s ovaries, fertilize them outside of the body and then transfer the embryos back to the uterus a few days later. These difficulties demand rethinking of assisted fertilization and the sought after novel approaches that offer more natural procedures with high success rate. Hence, we propose untethered medical microbots to assist sperm cells to fertilize an oocyte in living organisms (mice model). The MicroRepro project will bring advances in areas such as bioimaging, nanomaterials science and fundamental biology, boosting the whole field of medical microbots in the process, as was recently highlighted by the PI in an extended comment [Nature 545, 406(2017)]. The PI has decisively contributed to the field of microrobotics and invented the sperm-robot (Spermbot) concept together with his team in two previous patent applications and several publications. The mere concept has attracted worldwide attention. However, even in vitro fertilization has never been achieved – therefore, targeting the challenges leading to the first spermbot fertilization will be the main objective of this project.

Régime de financement

ERC-ADG - Advanced Grant

Institution d’accueil

TECHNISCHE UNIVERSITAET CHEMNITZ
Contribution nette de l'UE
€ 1 975 749,07
Adresse
STRASSE DER NATIONEN 62
09111 Chemnitz
Allemagne

Voir sur la carte

Région
Sachsen Chemnitz Chemnitz
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
€ 1 975 749,07

Bénéficiaires (2)